LTC2281831I2 - Varicella Zoster viruso vakcina - Google Patents

Varicella Zoster viruso vakcina

Info

Publication number
LTC2281831I2
LTC2281831I2 LTPA2018012C LTPA2018012C LTC2281831I2 LT C2281831 I2 LTC2281831 I2 LT C2281831I2 LT PA2018012 C LTPA2018012 C LT PA2018012C LT PA2018012 C LTPA2018012 C LT PA2018012C LT C2281831 I2 LTC2281831 I2 LT C2281831I2
Authority
LT
Lithuania
Prior art keywords
virus vaccine
zoster virus
varicella zoster
varicella
vaccine
Prior art date
Application number
LTPA2018012C
Other languages
English (en)
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34430592&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LTC2281831(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of LTPA2018012I1 publication Critical patent/LTPA2018012I1/lt
Publication of LTC2281831I2 publication Critical patent/LTC2281831I2/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
LTPA2018012C 2005-03-03 2018-09-20 Varicella Zoster viruso vakcina LTC2281831I2 (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0504436.7A GB0504436D0 (en) 2005-03-03 2005-03-03 Vaccine
EP20060707446 EP1858917B8 (en) 2005-03-03 2006-03-01 Varicella zoster virus vaccine

Publications (2)

Publication Number Publication Date
LTPA2018012I1 LTPA2018012I1 (lt) 2018-11-12
LTC2281831I2 true LTC2281831I2 (lt) 2020-08-25

Family

ID=34430592

Family Applications (4)

Application Number Title Priority Date Filing Date
LTEP10188256.1T LT2281831T (lt) 2005-03-03 2006-03-01 Varicella zoster viruso vakcina
LTEP10188214.0T LT2281830T (lt) 2005-03-03 2006-03-01 Varicella zoster viruso vakcina
LTEP10188215.7T LT2301955T (lt) 2005-03-03 2006-03-01 Varicella zoster viruso vakcina
LTPA2018012C LTC2281831I2 (lt) 2005-03-03 2018-09-20 Varicella Zoster viruso vakcina

Family Applications Before (3)

Application Number Title Priority Date Filing Date
LTEP10188256.1T LT2281831T (lt) 2005-03-03 2006-03-01 Varicella zoster viruso vakcina
LTEP10188214.0T LT2281830T (lt) 2005-03-03 2006-03-01 Varicella zoster viruso vakcina
LTEP10188215.7T LT2301955T (lt) 2005-03-03 2006-03-01 Varicella zoster viruso vakcina

Country Status (35)

Country Link
US (3) US20080171079A1 (lt)
EP (4) EP1858917B8 (lt)
JP (2) JP5420842B2 (lt)
KR (2) KR101357204B1 (lt)
CN (2) CN101189254B (lt)
AR (2) AR052498A1 (lt)
AU (1) AU2006222225B2 (lt)
BR (1) BRPI0607840B1 (lt)
CA (2) CA2882255C (lt)
CY (5) CY1116108T1 (lt)
DK (4) DK2301955T3 (lt)
EA (1) EA011884B1 (lt)
ES (4) ES2675054T3 (lt)
GB (1) GB0504436D0 (lt)
HK (1) HK1111427A1 (lt)
HR (4) HRP20150142T1 (lt)
HU (4) HUE032544T2 (lt)
IL (1) IL185442A (lt)
LT (4) LT2281831T (lt)
LU (1) LUC00087I2 (lt)
MA (1) MA29714B1 (lt)
MX (2) MX2007010626A (lt)
MY (1) MY148464A (lt)
NL (1) NL300951I2 (lt)
NO (1) NO341841B1 (lt)
NZ (1) NZ561075A (lt)
PE (2) PE20061287A1 (lt)
PL (4) PL1858917T3 (lt)
PT (4) PT2301955T (lt)
SI (4) SI1858917T1 (lt)
TR (2) TR201809397T4 (lt)
TW (1) TWI403517B (lt)
UA (1) UA94900C2 (lt)
WO (1) WO2006094756A2 (lt)
ZA (1) ZA200707144B (lt)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
TWI457133B (zh) * 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
AU2008275895A1 (en) * 2007-07-19 2009-01-22 Novavax, Inc. Varicella Zoster Virus-virus like particles (VLPS) and antigens
FR2952825B1 (fr) 2009-11-24 2012-05-25 Goaster Jacqueline Le Utilisation d'un vaccin contre le virus vzv/hsv3 pour traiter les infections herpetiques par le virus hsv1 et/ou le virus hsv2
JP5940064B2 (ja) 2010-07-06 2016-06-29 ノバルティス アーゲー 低用量のｒｎａを用いた大型哺乳動物の免疫化
SI3243526T1 (sl) 2010-07-06 2020-02-28 Glaxosmithkline Biologicals S.A. Dostava RNA za sprožitev večih imunskih poti
PL2590626T3 (pl) 2010-07-06 2016-04-29 Glaxosmithkline Biologicals Sa Liposomy z lipidami o korzystnej wartości pka do dostarczania rna
UA112970C2 (uk) * 2010-08-05 2016-11-25 Мерк Шарп Енд Доме Корп. Інактивований вірус вітряної віспи, спосіб його одержання і застосування
HRP20230185T8 (hr) 2010-08-31 2023-07-21 Glaxosmithkline Biologicals Sa Pegilirani liposomi za isporuku rna koja kodira imunogen
EP4098325A1 (en) 2010-10-11 2022-12-07 GlaxoSmithKline Biologicals S.A. Antigen delivery platforms
WO2013006838A1 (en) 2011-07-06 2013-01-10 Novartis Ag Immunogenic combination compositions and uses thereof
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
KR20160067087A (ko) * 2013-10-03 2016-06-13 닛토덴코 가부시키가이샤 주사 백신 조성물
JP6499420B2 (ja) * 2014-11-13 2019-04-10 公益財団法人ヒューマンサイエンス振興財団 ワクチン及び感染防御キット
CA2970840A1 (en) * 2014-12-18 2016-06-23 Glaxosmithkline Biologicals S.A. Vaccine composition comprising truncated varicella zoster virus glycoprotein e antigen
BE1022523B1 (fr) * 2014-12-18 2016-05-20 Glaxosmithkline Biologicals Sa Vaccination
PL3718565T3 (pl) 2015-10-22 2022-09-19 Modernatx, Inc. Szczepionki przeciwko wirusom układu oddechowego
CN117731769A (zh) * 2015-10-22 2024-03-22 摩登纳特斯有限公司 用于水痘带状疱疹病毒(vzv)的核酸疫苗
EP4001290A1 (en) 2015-11-06 2022-05-25 Adjuvance Technologies, Inc. Triterpene saponin analogues
MA46766A (fr) 2016-11-11 2019-09-18 Modernatx Inc Vaccin antigrippal
WO2018097642A1 (ko) * 2016-11-25 2018-05-31 재단법인 목암생명과학연구소 바리셀라 조스터 바이러스 백신
CN110035772B (zh) * 2016-11-25 2023-07-18 财团法人牧岩生命科学研究所 水痘带状疱疹病毒疫苗
CN107022559A (zh) * 2016-12-08 2017-08-08 长春祈健生物制品有限公司 一种水痘‑带状疱疹病毒糖蛋白e胞外区蛋白的制备方法
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
MX2019007288A (es) * 2016-12-26 2019-10-02 Mogam Inst Biomedical Res Composicion de vacuna para herpes zoster.
CN108727503A (zh) * 2017-04-18 2018-11-02 武汉博沃生物科技有限公司 VZV重组gE-鞭毛素融合蛋白及其制备方法和应用
WO2018200656A1 (en) * 2017-04-25 2018-11-01 Adjuvance Technologies, Inc. Triterpene saponin analogues
EP3618836A4 (en) * 2017-04-25 2021-01-13 Adjuvance Technologies, Inc. TRITERPENSAPONINALOGA
WO2018198085A1 (en) 2017-04-28 2018-11-01 Glaxosmithkline Biologicals Sa Vaccination
GB201707700D0 (en) 2017-05-12 2017-06-28 Glaxosmithkline Biologicals Sa Dried composition
EP3630176A1 (en) 2017-05-30 2020-04-08 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
AU2018350887A1 (en) 2017-10-16 2020-03-05 Adjuvance Technologies, Inc. Triterpene saponin analogues
JP2021504424A (ja) 2017-12-01 2021-02-15 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
CN108315344A (zh) * 2018-02-14 2018-07-24 武汉博沃生物科技有限公司 Vzv糖蛋白e基因表达载体及其重组酵母菌株与应用
KR102337922B1 (ko) 2018-04-19 2021-12-09 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
KR20190121956A (ko) 2018-04-19 2019-10-29 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
AU2019272184B2 (en) * 2018-05-23 2022-01-27 Mogam Institute For Biomedical Research Antigen variant of varicella zoster virus and use thereof
EP3833382A1 (en) 2018-08-07 2021-06-16 GlaxoSmithKline Biologicals S.A. Processes and vaccines
CN108992667A (zh) * 2018-08-09 2018-12-14 安徽智飞龙科马生物制药有限公司 一种带状疱疹疫苗及其制备方法、应用
KR102270048B1 (ko) * 2020-07-10 2021-06-28 주식회사 녹십자 바리셀라 조스터 바이러스 표면 단백질 항원의 생산 방법
AU2019349036A1 (en) * 2018-09-27 2021-06-03 Bravovax Co., Ltd Immune composition, preparation method therefor, and application thereof
WO2020109365A1 (en) 2018-11-29 2020-06-04 Glaxosmithkline Biologicals Sa Methods for manufacturing an adjuvant
CN109602901B (zh) * 2019-01-08 2022-05-27 成都迈科康生物科技有限公司 一种带状疱疹病毒疫苗及其制备方法和应用
EP3980044A1 (en) 2019-06-05 2022-04-13 GlaxoSmithKline Biologicals SA Saponin purification
CN112142828B (zh) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 一种gE基因及表达该基因的载体
KR20220114032A (ko) * 2019-12-13 2022-08-17 그랜드 테라박 라이프 사이언스 (난징) 씨오., 엘티디. 약물 조성물 및 그 용도
KR20210110242A (ko) * 2020-02-28 2021-09-07 (주)셀트리온 수두 대상포진 바이러스 융합 단백질 및 이를 포함하는 면역원성 조성물
AU2021321944A1 (en) 2020-08-07 2023-04-06 Access To Advanced Health Institute Purified saponins and chromatographic process for purification of same
WO2022055176A1 (ko) * 2020-09-11 2022-03-17 주식회사 유바이오로직스 수두 또는 대상포진 백신 조성물 및 이를 이용하는 방법
RU2750818C1 (ru) * 2020-11-19 2021-07-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова Вирусный штамм для получения аттенуированной живой культуральной вакцины для профилактики и лечения опоясывающего герпеса для взрослого населения
WO2023056912A1 (en) * 2021-10-08 2023-04-13 Suzhou Abogen Biosciences Co., Ltd. Nucleic acid vaccines for vzv
WO2023064612A2 (en) 2021-10-15 2023-04-20 BioNTech SE Pharmaceutical compositions for delivery of viral antigens and related methods
WO2023096963A1 (en) 2021-11-24 2023-06-01 Flagship Pioneering Innovations Vi, Llc Varicella-zoster virus immunogen compositions and their uses
CN116350770A (zh) * 2021-12-28 2023-06-30 成都迈科康生物科技有限公司 一种带状疱疹疫苗制剂及其制备方法
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5341202B2 (lt) 1974-03-12 1978-11-01
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4769239A (en) 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
CA1331443C (en) 1987-05-29 1994-08-16 Charlotte A. Kensil Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
ATE119939T1 (de) 1989-06-27 1995-04-15 Smithkline Beecham Biolog Verbindungen.
EP0468520A3 (en) 1990-07-27 1992-07-01 Mitsui Toatsu Chemicals, Inc. Immunostimulatory remedies containing palindromic dna sequences
ZA929870B (en) 1991-12-23 1993-08-18 Duphar Int Res Adjuvants
EP0761231B1 (en) 1992-06-25 2000-01-12 SMITHKLINE BEECHAM BIOLOGICALS s.a. Vaccine composition containing adjuvants
ES2165367T5 (es) 1992-07-17 2009-08-05 MERCK & CO., INC. Procedimiento para prevenir el herpes zoster o para aliviar la neuralgia post-herpetica relacionada con la varicela.
DK0689454T4 (da) 1993-03-23 2005-05-30 Smithkline Beecham Biolog Vaccinepræparater indeholdende 3-O-deacyleret monophosphoryl-lipid A
US5976552A (en) * 1995-04-28 1999-11-02 Protein Sciences Corporation Virus vaccines
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
EP1167377B2 (en) 1994-07-15 2012-08-08 University of Iowa Research Foundation Immunomodulatory oligonucleotides
AUPM873294A0 (en) 1994-10-12 1994-11-03 Csl Limited Saponin preparations and use thereof in iscoms
WO1996029408A1 (en) * 1995-03-23 1996-09-26 Immunex Corporation Il-17 receptor
UA56132C2 (uk) * 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
US6846489B1 (en) 1995-04-25 2005-01-25 Smithkline Beecham Biologicals S.A. Vaccines containing a saponin and a sterol
KR0177323B1 (ko) * 1996-02-16 1999-04-01 성재갑 바이러스 백신 생산에 유용한 사람 이배체 폐세포 및 이를 이용한 수두 백신의 제조방법
AU743114B2 (en) 1997-04-01 2002-01-17 Corixa Corporation Aqueous immunologic adjuvant compositions of monophosphoryl lipid A
GB9718901D0 (en) 1997-09-05 1997-11-12 Smithkline Beecham Biolog Vaccine
ES2201551T3 (es) 1997-09-05 2004-03-16 Glaxosmithkline Biologicals S.A. Emulsiones de aceite en agua que contienen saponinas.
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
EP1326638B9 (en) 2000-10-18 2008-02-20 GlaxoSmithKline Biologicals S.A. Vaccines against cancers
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
EA200701632A1 (ru) 2008-02-28
CN103028113A (zh) 2013-04-10
CN101189254B (zh) 2013-05-22
HUS1800038I1 (hu) 2018-10-29
PL2301955T3 (pl) 2018-08-31
PT2301955T (pt) 2018-06-18
US20080171079A1 (en) 2008-07-17
PT2281830T (pt) 2017-02-24
MX346865B (es) 2017-04-04
ZA200707144B (en) 2009-11-25
SI1858917T1 (sl) 2015-03-31
LT2281831T (lt) 2018-07-10
ES2675055T3 (es) 2018-07-06
LUC00087I2 (lt) 2018-11-26
CY1118629T1 (el) 2017-07-12
HRP20180988T1 (hr) 2018-08-10
ES2532803T3 (es) 2015-03-31
CA2600905C (en) 2015-05-05
HUE038468T2 (hu) 2018-10-29
EP2281831B1 (en) 2018-04-18
MX2007010626A (es) 2007-10-16
CY1120347T1 (el) 2018-12-12
EP2281831A3 (en) 2011-11-16
EA011884B1 (ru) 2009-06-30
NO341841B1 (no) 2018-02-05
HRP20180989T1 (hr) 2018-08-10
EP1858917A2 (en) 2007-11-28
ES2618037T3 (es) 2017-06-20
MA29714B1 (fr) 2008-09-01
LTPA2018012I1 (lt) 2018-11-12
DK2281830T3 (en) 2017-03-20
CA2882255A1 (en) 2006-09-14
EP1858917B1 (en) 2014-12-24
EP2301955A2 (en) 2011-03-30
AR052498A1 (es) 2007-03-21
JP2008531637A (ja) 2008-08-14
TWI403517B (zh) 2013-08-01
NO20074392L (no) 2007-11-27
MY148464A (en) 2013-04-30
IL185442A0 (en) 2008-01-06
EP2281831A2 (en) 2011-02-09
WO2006094756A3 (en) 2007-02-15
CY1116108T1 (el) 2017-02-08
HRP20170081T1 (hr) 2017-03-24
NL300951I1 (nl) 2018-09-26
DK2301955T3 (en) 2018-06-14
KR20070110413A (ko) 2007-11-16
PL2281831T3 (pl) 2018-08-31
BRPI0607840B1 (pt) 2021-06-29
NL300951I2 (nl) 2020-08-31
PL1858917T3 (pl) 2015-05-29
TR201809393T4 (tr) 2018-07-23
CN103028113B (zh) 2015-05-20
TW200643028A (en) 2006-12-16
AU2006222225B2 (en) 2012-08-16
KR101357204B1 (ko) 2014-02-06
AR107285A2 (es) 2018-04-18
IL185442A (en) 2013-07-31
NZ561075A (en) 2009-06-26
SI2301955T1 (en) 2018-07-31
HK1111427A1 (en) 2008-08-08
US20110045059A1 (en) 2011-02-24
EP2301955A3 (en) 2011-11-16
JP2013144710A (ja) 2013-07-25
PE20100658A1 (es) 2010-10-23
HUE038467T2 (hu) 2018-10-29
CA2882255C (en) 2018-03-27
EP2281830B1 (en) 2016-12-21
PT1858917E (pt) 2015-02-24
LT2281830T (lt) 2017-02-10
CY1121211T1 (el) 2020-05-29
JP5840167B2 (ja) 2016-01-06
TR201809397T4 (tr) 2018-07-23
UA94900C2 (uk) 2011-06-25
EP1858917B8 (en) 2015-05-06
HUE032544T2 (en) 2017-10-30
CY2018025I2 (el) 2018-12-12
SI2281831T1 (en) 2018-07-31
PE20061287A1 (es) 2006-12-07
LT2301955T (lt) 2018-07-10
EP2281830A2 (en) 2011-02-09
WO2006094756A2 (en) 2006-09-14
CN101189254A (zh) 2008-05-28
PL2281830T3 (pl) 2017-06-30
DK1858917T3 (da) 2015-02-02
CA2600905A1 (en) 2006-09-14
DK2281831T3 (en) 2018-06-14
PT2281831T (pt) 2018-06-15
CY2018025I1 (el) 2018-12-12
AU2006222225A1 (en) 2006-09-14
KR20140006115A (ko) 2014-01-15
EP2301955B1 (en) 2018-04-18
HRP20150142T1 (hr) 2015-05-22
SI2281830T1 (sl) 2017-03-31
BRPI0607840A2 (pt) 2009-06-13
ES2675054T3 (es) 2018-07-06
US20110104260A1 (en) 2011-05-05
JP5420842B2 (ja) 2014-02-19
GB0504436D0 (en) 2005-04-06
EP2281830A3 (en) 2012-01-25
US7939084B1 (en) 2011-05-10

Similar Documents

Publication Publication Date Title
LTC2281831I2 (lt) Varicella Zoster viruso vakcina
AR058706A1 (es) Vacuna
DK1926496T3 (da) PCV-2-vaccine
DK1957528T3 (da) Nukleotid-vaccine
DK1968994T3 (da) Syntetiske genomer
DK1942933T3 (da) Hundeinfluenzavacciner
ATE487718T1 (de) Substituierte bizyklische pyrimidonderivate
DK1877549T3 (da) HIV-vaccine
ATE503733T1 (de) Estrich
ITMO20050279A1 (it) Apparato di aspirazione
ES1059358Y (es) Azulejo
UA13238S (uk) Тротуарна плитка
UA13235S (uk) Тротуарна плитка
UA13251S (uk) Плитка тротуарна
UA13233S (uk) Тротуарна плитка
UA13234S (uk) Тротуарна плитка
UA13237S (uk) Тротуарна плитка
UA13236S (uk) Тротуарна плитка
UA13250S (uk) Тротуарна плитка
FI7018U1 (fi) Kirves
ITMI20051041A1 (it) Piccozza
DE502006005392D1 (de) Autobahnassistent
ITTO20050219A1 (it) Attacco leggero
ITTO20050776A1 (it) Banco tagliatronchi
ITMI20050375U1 (it) Cazzuola